Abstract
In February 1972 58% of patients euthyroid after iodine-131 therapy given for thyrotoxicosis between 1954 and 1966 had a high plasma TSH (>7·4 μU/ml) and 42% a normal plasma TSH level. A group of 69 of the euthyroid patients with high plasma TSH levels (25·0±2·0 μU/ml) in 1972 were re-examined 15 and 24 months later. The mean plasma TSH in the 66 patients remaining euthyroid at 15 months was 22·6±1·8 μU/ml, while three patients had become hypothyroid. At 24 months 64 of the patients were still available for study, of whom 61 remained euthyroid with a mean plasma TSH of 21·6±2·0 μU/ml, and a further three had become hypothyroid.
All of a group of 61 of the euthyroid patients with normal plasma TSH levels (4·0±0·2 μU/ml) in 1972 remained euthyroid at 24 months with a mean plasma TSH of 4·1±0·3 μU/ml, though the plasma TSH level had become slightly raised in three.
The mean serum T-4 level in the euthyroid patients with a high plasma TSH was significantly lower, though still in the normal range, than that in the euthyroid patients with a normal plasma TSH both in 1972 and in 1974.
Since no patient with a normal plasma TSH level after iodine-131 treatment six to 18 years earlier for thyrotoxicosis developed hypothyroidism over a two-year period, the follow-up of such patients need not be so rigorous as that of similarly treated euthyroid patients with raised plasma TSH levels in whom hypothyroidism developed at the rate of 5% per year.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bellabarba D., Bénard B., Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotrophin after treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 1972 Oct;1(4):345–353. doi: 10.1111/j.1365-2265.1972.tb00404.x. [DOI] [PubMed] [Google Scholar]
- Bradfield R. B., Jourdan M. H. Relative importance of specific dynamic action in weight-reduction diets. Lancet. 1973 Sep 22;2(7830):640–643. doi: 10.1016/s0140-6736(73)92479-3. [DOI] [PubMed] [Google Scholar]
- Hagen G. A. Treatment of thyrotoxicosis with 131-I and post-therapy hypothryoidism. Med Clin North Am. 1968 Mar;52(2):417–429. [PubMed] [Google Scholar]
- Irvine W. J., Toft A. D., Hunter W. M., Kirkham K. E. An assessment of plasma TSH radioimmunoassay and of the TSH stimulation test in the diagnosis of 100 consecutive patients with suspected hypothyroidism. Clin Endocrinol (Oxf) 1973 Apr;2(2):135–139. doi: 10.1111/j.1365-2265.1973.tb00413.x. [DOI] [PubMed] [Google Scholar]
- Slingerland D. W., Hershman J. M., Dell E. S., Burrows B. A. Thyrotropin and PBI in radioiodine treated hyperthyroid patients. J Clin Endocrinol Metab. 1972 Dec;35(6):912–917. doi: 10.1210/jcem-35-6-912. [DOI] [PubMed] [Google Scholar]
- Toft A. D., Seth J., Hunter W. M., Irvine W. J. Plasma-thyrotrophin and serum-thyroxine in patients becoming hypothyroid in the early months after iodine-131. Lancet. 1974 Apr 20;1(7860):704–705. doi: 10.1016/s0140-6736(74)92905-5. [DOI] [PubMed] [Google Scholar]